Picard Medical prices $17M IPO at $4/share; commences trading on NYSE American under PMI

Picard Medical, Inc.

4,250,000 shares sold at $4.00 for $17M gross proceeds; over-allotment option for 637,500 additional shares.
Proceeds to support China JV, R&D on fully implantable Emperor heart, and debt repayment.
Shares commenced trading on NYSE American on Aug 29, 2025 under ticker 'PMI'.
Underwriting Agreement with WestPark Capital as lead manager; firm commitment basis.

item 1.01item 5.02item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.